Video Game-Like grip trainer boosts fistula health in kidney patients
NCT ID NCT05686200
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using a smart grip device with a game-like app could improve blood vessel function and hand strength in 52 kidney patients who had just had a first arteriovenous fistula surgery. Participants used the device daily for eight weeks, and researchers tracked changes in fistula maturity and grip strength. The goal was to see if making exercise fun could help patients stick with it and get better results.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- intelligent forearm isometric exercise device with game software
- What this could lead to
- If it works, this could offer a simple, engaging way for kidney patients to improve fistula health and hand strength after surgery.
- What could go wrong
- This is a small, completed study with only 52 participants, so results may not apply to everyone. The exercise device is not a standard treatment and may not be widely available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
52 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 20 years old * Regular follow-up in the nephrology clinic * Diagnosed with chronic kidney disease at stage 5 (or 5D) * Expect to do the first autologous arteriovenous fistula surgery Exclusion Criteria: * Not the first autologous arteriovenous fistula surgery * Have undergone percutaneous transluminal angioplasty in the arm receiving autologous arteriovenous fistula * Have undergone orthopedic disease-related surgery in the arm receiving autologous arteriovenous fistula * Have been cardiovascular events within the past 3 months * Have been heart function Left ventricular ejection fraction within the past 3 months \<30%.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arteriovenous fistula are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taipei University of Nursing and Health Sciences
Taipei, Taipei City, 112303, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do kidney patients know why a fistula matters before dialysis?
- Could pistachios be safe for failing kidneys? trial tests a forbidden snack
- A conversation starter for kidney care: can a checklist give older patients a stronger voice?
- Choosing dialysis or transplant: does a shared approach lead to better decisions?
- Can light therapy speed up dialysis fistula healing?
- Could a little fat be the key to better dialysis access?